| PRD_002187 | Name: | tert-butyl [(4S,7S,10S)-7-(cyclohexylmethyl)-10-(hydroxymethyl)-5,8,13-trioxo-23-oxa-6,9,14,21,22-pentaazabicyclo[18.2.1]tricosa-1(22),20-dien-4-yl]carbamate | Formula: | C30 H50 N6 O7 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
| PRD_002189 | Name: | tert-butyl [(4S,7S,10S)-7-(cyclohexylmethyl)-10-(hydroxymethyl)-5,8,13-trioxo-22-oxa-6,9,14,20,21-pentaazabicyclo[17.2.1]docosa-1(21),19-dien-4-yl]carbamate | Formula: | C29 H48 N6 O7 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
| PRD_002250 | Name: | N,N-diethyl-N~2~-(3-phenylpropanoyl)-L-asparaginyl-O-methyl-N-[(naphthalen-1-yl)methyl]-L-serinamide | Formula: | C32 H40 N4 O5 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
| PRD_002252 | Name: | N,N-diethyl-N~2~-[(2E)-3-phenylprop-2-enoyl]-L-asparaginyl-4-fluoro-N-[(naphthalen-1-yl)methyl]-L-phenylalaninamide | Formula: | C37 H39 F N4 O4 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
| PRD_002255 | Name: | N,N-diethyl-N~2~-(3-phenylpropanoyl)-L-asparaginyl-N-[(naphthalen-1-yl)methyl]-L-alaninamide | Formula: | C31 H38 N4 O4 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
| PRD_002272 | Name: | (3R)-3,6-diamino-N-({(2R,5R,8Z,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-5-yl}methyl)hexanamide | Formula: | C25 H44 N14 O7 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
| PRD_002289 | Name: | 3-[(3R,6S,9S,12S,15S,18S,21S,24R,27S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-(propan-2-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29-octacosahydro-1H-1,4,7,10,13,16,19,22,25,28-benzodecaazacyclohentriacontin-18-yl]propanamide | Formula: | C68 H85 N13 O13 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
| PRD_002290 | Name: | 4-[(3R,6S,9S,12S,15S,18S,21S,24R,27S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-(propan-2-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29-octacosahydro-1H-1,4,7,10,13,16,19,22,25,28-benzodecaazacyclohentriacontin-18-yl]butan-1-aminium | Formula: | C69 H90 N13 O12 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
| PRD_002295 | Formula: | C89 H131 N23 O25 S3 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
| PRD_000734 | Name: | ALL-D KALATA B1 | Formula: | C117 H180 N35 O39 S6 | Definition date: | 2020-08-12 | Last modified: | 2023-09-20 |
|
| PRD_000749 | Name: | KALATA B1 | Formula: | C117 H180 N35 O39 S6 | Definition date: | 2020-08-12 | Last modified: | 2023-09-20 |
|
| PRD_000752 | Name: | CIRCULIN A | Formula: | C134 H211 N38 O38 S6 | Definition date: | 2020-08-12 | Last modified: | 2023-09-20 |
|
| PRD_002363 | Formula: | C73 H120 N20 O13 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
| PRD_002365 | Name: | phazolicin | Formula: | C74 H104 N29 O27 S3 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
| PRD_002267 | Name: | D-Arg4,Leu10-Teixobactin | Formula: | C59 H101 N14 O14 | Definition date: | 2020-08-19 | Last modified: | 2020-08-19 |
|
| PRD_002268 | Name: | Lipid II | Formula: | C54 H91 N8 O26 P2 | Definition date: | 2020-08-19 | Last modified: | 2023-06-11 |
|
| PRD_002315 | Name: | 4HP-PRO-LYS-ARG-NH2, BM-30 | Formula: | C25 H42 N8 O5 | Definition date: | 2020-08-26 | Last modified: | 2020-08-26 |
|
| PRD_002352 | Formula: | C22 H31 N3 O7 | Definition date: | 2020-09-02 | Last modified: | 2020-09-02 |
|
| PRD_002435 | Formula: | C49 H86 N5 O8 | Definition date: | 2020-09-16 | Last modified: | 2023-11-03 |
|
| PRD_002372 | Name: | ACE-VAL-ARG-MET-QZA | Formula: | C22 H43 Cl N7 O5 S | Definition date: | 2020-09-16 | Last modified: | 2020-09-16 |
|
| PRD_002373 | Name: | ACE-VAL-ARG-MET-B2A | Formula: | C20 H41 B N7 O6 S | Definition date: | 2020-09-16 | Last modified: | 2020-09-16 |
|
| PRD_002448 | Name: | (1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide | Formula: | C36 H55 N7 O6 | Definition date: | 2020-09-30 | Last modified: | 2020-09-30 |
|
| PRD_002449 | Name: | (ACE)(1MH)D(B3L)F(1U8) | Formula: | C44 H54 N6 O12 | Definition date: | 2020-09-30 | Last modified: | 2020-09-30 |
|
| PRD_002450 | Name: | (ACE)(1MH)D(PF5)F(1U8) | Formula: | C46 H45 F5 N6 O12 | Definition date: | 2020-09-30 | Last modified: | 2020-09-30 |
|
| PRD_002447 | Name: | (1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide | Formula: | C36 H55 N7 O6 | Definition date: | 2020-10-07 | Last modified: | 2020-10-14 |
|